Peptide YY and cancer: current findings and potential clinical applications

Peptides. 2002 Feb;23(2):389-95. doi: 10.1016/s0196-9781(01)00616-7.

Abstract

Peptide YY (PYY) is a naturally occurring gut hormone with mostly inhibitory actions on multiple tissue targets. PYY has been identified in several carcinoid tumors and a decreased expression of PYY may be relevant to the development and progression of colon adenocarcinoma. Treatment with PYY decreases growth in pancreatic and breast tumors, most likely through a reduction in intracellular cAMP. In cancer patients, PYY may also improve malnutrition that results from iatrogenic causes or cachexia associated with advanced disease. PYY plays a significant role in multiple aspects of cancer from regulation of cell growth to potential therapeutic applications.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / metabolism*
  • Breast Neoplasms / metabolism
  • Cachexia / metabolism
  • Carcinoid Tumor / metabolism*
  • Cell Division
  • Colonic Neoplasms / metabolism*
  • Cyclic AMP / metabolism
  • Humans
  • Pancreatic Neoplasms / metabolism
  • Peptide YY / genetics*
  • Peptide YY / metabolism*
  • Time Factors

Substances

  • Peptide YY
  • Cyclic AMP